Canopy Growth Corporation

NASDAQ:CGC

Drug Manufacturers - Specialty & Generic

Healthcare
$0.50 +1.07%

+$0.01 today

Market cap
$212.31M
Beta
0.78
P/E (TTM)
-1.8
EPS (TTM)
-$0.76
52W Low $0.84High $2.38

Volume 3.44M

Average 9.97M

CGC Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Canopy Growth CorporationNASDAQ: CGC

Gross Margin · Q4 FY2025 · quarter ended Mar 2026

Gross margin narrows to 11.6%

Gross margin was 11.6% in Q4 FY2025, down 4.6 pp from a year earlier. On a trailing-twelve-month basis it was 24.9%, down 4.7 pp year over year. Over 3 fiscal years it widened by 39.2 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
11.6%-17.2 pp QoQ
Last fiscal yearMar 2026
20.1%-9.5 pp YoY
LTMMar 2026
24.9%-4.7 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-4.6 pp——
1 year-9.5 pp——
3 years+39.2 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
20.1%
Year-over-year change
-9.5pp

Gross Margin vs competitors

How CGC compares with its peers on the latest reported figures

  • CGC's LTM Mar 2026 gross margin of 24.9% is the 8th highest of the 9 companies compared; the peer median is 64.6%.
  • Its year-over-year change of -4.7 pp is the 7th highest of 8, against a peer median of +2.0 pp.
  • Over three fiscal years its change of +39.2 pp compares with a peer median of -3.8 pp.
CGC Competitors Peer median
Gross Margin for CGC and competitors
Company Period LTM level YoY 3-year change
IRWDIronwood Pharmaceuticals, Inc.LTM Mar 202699.6% +17.6 pp+0.3 pp
BIOABioAge Labs, Inc.LTM Mar 202699.4% -0.6 pp—
ACRSAclaris Therapeutics, Inc.LTM Mar 202676.3% +55.8 pp+13.5 pp
DHDefinitive Healthcare Corp.LTM Mar 202672.5% -4.4 pp-5.0 pp
ACBAurora Cannabis Inc.LTM Mar 202656.6% +2.0 pp-1.4 pp
TKNOAlpha Teknova, Inc.LTM Mar 202633.3% +12.3 pp-9.0 pp
LFCRLifecore Biomedical, Inc.LTM Mar 202631.2% —-3.8 pp
CGCCanopy Growth CorporationLTM Mar 202624.9% -4.7 pp+39.2 pp
LYELLyell Immunopharma, Inc.LTM Mar 2026-7422.6% -7522.6 pp-32052.8 pp
CABACabaletta Bio, Inc.FY2025— ——
Peer median (excluding CGC) 64.6%+2.0 pp-3.8 pp

Competitors are the stored peer set for CGC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Revenue475.7M333.25M297.15M269M483.67M
Cost of Revenue663.11M396.78M216.26M189.48M386.51M
Gross Profit(187.41M)(63.53M)80.88M79.51M97.16M
Gross Margin-39.4%-19.1%27.2%29.6%20.1%
Research & Development32.26M21.72M4.61M1.91M0
Selling, General & Admin361.1M297.98M180.59M121.71M223.11M
Operating Expenses831.39M2.57B309.6M196.65M322.6M
Depreciation & Amortization110.94M80.03M53.18M43.12M50.86M
EBITDA(52.98M)(2.88B)(312.83M)(479.31M)50.86M
EBITDA Margin-11.1%-864.2%-105.3%-178.2%10.5%
Operating Income(1.02B)(2.63B)(228.71M)(117.14M)(161.66M)
Operating Margin-214.2%-789.3%-77.0%-43.5%-33.4%
Interest Income6.6M24.28M16.24M8.82M10M
Interest Expense103.94M126.16M105.35M74.57M38.19M
Other Income / Expenses750.94M(455.64M)(242.64M)(479.85M)(101.23M)
Income Before Tax(267.86M)(3.09B)(471.36M)(597M)(262.89M)
Pre-Tax Margin-56.3%-926.1%-158.6%-221.9%-54.4%
Income Tax Expense(8.95M)(5.73M)12.33M7.14M23K
Net Income(310.04M)(3.28B)(657.27M)(598.12M)(366.64M)
Net Margin-65.2%-983.7%-221.2%-222.4%-75.8%
EPS (Basic)(7.70)(70.70)(6.47)(5.53)(0.88)
EPS (Diluted)(7.70)(70.70)(8.79)(5.53)(0.88)
Weighted Avg Shares39.13M46.37M101.63M107.55M2.98B
Weighted Avg Shares (Diluted)39.13M46.37M74.79M107.55M2.98B

Canopy Growth Corporation

NASDAQ:CGC

Intrinsic Alpha fair value

Locked

Current Price

$0.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.